NCT03620032 2023-12-06DIPGFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2 Unknown54 enrolled
NCT00600054 2011-07-06Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine GliomaYM BioSciencesPhase 2 Completed44 enrolled